CTI BioPharma Corp CTIC

NAS: CTIC | ISIN: US12648L6011   23/06/2023
9,090 USD (0,00%)
(0,00%)   23/06/2023

30 mei 2023 · CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders · Persbericht

16 mei 2023 · Moore Kuehn Encourages HMPT, ABST, CTIC and FRG Investors to Contact Law Firm · Persbericht

10 mei 2023 · Sobi to Acquire CTI BioPharma · Persbericht

5 mei 2023 · CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

2 mei 2023 · CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

1 mei 2023 · CTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023 · Persbericht

1 mei 2023 · CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting · Persbericht

12 april 2023 · CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023 · Persbericht

11 april 2023 · CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

21 maart 2023 · CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

6 maart 2023 · CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

6 maart 2023 · CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results · Persbericht

1 maart 2023 · CTI BioPharma to Present at the 43rd Annual Cowen Health Care Conference · Persbericht

23 februari 2023 · CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023 · Persbericht

8 februari 2023 · CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

2 februari 2023 · CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023 · Persbericht

25 januari 2023 · CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

5 januari 2023 · CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference · Persbericht

21 december 2022 · CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

12 december 2022 · CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition · Persbericht

Mijn selecties